I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 21% ± 4% | |
| epithelial cell | 4 studies | 26% ± 8% | |
| non-classical monocyte | 3 studies | 20% ± 4% | |
| glutamatergic neuron | 3 studies | 27% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 8 studies | 21% ± 4% | |
| epithelial cell | 4 studies | 26% ± 8% | |
| non-classical monocyte | 3 studies | 20% ± 4% | |
| glutamatergic neuron | 3 studies | 27% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 19% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 570.10 | 1445 / 1445 | 100% | 6.04 | 183 / 183 |
| ovary | 100% | 464.81 | 180 / 180 | 100% | 4.30 | 430 / 430 |
| thymus | 100% | 535.97 | 653 / 653 | 100% | 4.21 | 605 / 605 |
| breast | 100% | 572.73 | 459 / 459 | 100% | 4.48 | 1117 / 1118 |
| lung | 100% | 610.01 | 577 / 578 | 100% | 4.39 | 1155 / 1155 |
| brain | 100% | 550.02 | 2637 / 2642 | 100% | 6.08 | 705 / 705 |
| uterus | 100% | 528.44 | 170 / 170 | 100% | 4.43 | 458 / 459 |
| prostate | 100% | 532.72 | 244 / 245 | 100% | 4.58 | 502 / 502 |
| kidney | 100% | 585.98 | 89 / 89 | 100% | 4.63 | 897 / 901 |
| bladder | 100% | 580.10 | 21 / 21 | 99% | 4.12 | 501 / 504 |
| adrenal gland | 100% | 511.39 | 258 / 258 | 99% | 4.72 | 228 / 230 |
| stomach | 100% | 430.77 | 359 / 359 | 99% | 5.34 | 283 / 286 |
| intestine | 100% | 611.10 | 966 / 966 | 99% | 4.70 | 521 / 527 |
| skin | 100% | 595.80 | 1808 / 1809 | 97% | 4.31 | 456 / 472 |
| pancreas | 97% | 237.70 | 317 / 328 | 99% | 3.77 | 177 / 178 |
| liver | 100% | 301.01 | 226 / 226 | 96% | 2.57 | 389 / 406 |
| adipose | 100% | 665.30 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 669.05 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 4.06 | 29 / 29 |
| muscle | 100% | 691.82 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 690.42 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 3.86 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.30 | 1 / 1 |
| heart | 99% | 629.48 | 851 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 88% | 2.69 | 70 / 80 |
| peripheral blood | 84% | 294.37 | 779 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0070126 | Biological process | mitochondrial translational termination |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0003747 | Molecular function | translation release factor activity |
| GO_0016149 | Molecular function | translation release factor activity, codon specific |
| Gene name | MTRF1L |
| Protein name | Mitochondrial translation release factor 1 like Peptide chain release factor 1-like, mitochondrial (Mitochondrial translational release factor 1-like) (mtRF1a) |
| Synonyms | MTRF1A |
| Description | FUNCTION: Mitochondrial peptide chain release factor that directs the termination of translation in response to the peptide chain termination codons UAA and UAG. . |
| Accessions | Q5TF45 ENST00000367230.5 [Q9UGC7-4] Q9UGC7 ENST00000414771.5 ENST00000367231.9 [Q9UGC7-2] ENST00000448966.1 ENST00000367233.10 [Q9UGC7-1] X6RKB4 |
